Intraperitoneal Carboplatin Boosts PFS in Ovarian Cancer

(MedPage Today) -- PHOENIX--Combined with dose-dense paclitaxel, intraperitoneal (IP) carboplatin bested intravenous (IV) carboplatin for progression-free survival (PFS) in patients with ovarian, fallopian tube, or primary peritoneal cancer...